Dual delivery of an NF-κB inhibitor and IL-10 through supramolecular hydrogels polarizes macrophages and promotes cardiac repair after myocardial infarction-Reference-Cited by-同舟云学术

Dual delivery of an NF-κB inhibitor and IL-10 through supramolecular hydrogels polarizes macrophages and promotes cardiac repair after myocardial infarction

Published:2023-07 Issue: Volume:164 Page:111-123
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Wang Di,Hu Yang,Zhang Lili,Cai Haijian,Wang Yaguang,Zhang Ye

Funder

NSFC

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference48 articles.

1. Reducing the incidence and mortality from myocardial infarction;Reed;Lancet Public Health,2022

2. Long-term trends in the incidence of heart failure after myocardial infarction;Velagaleti;Circulation,2008

3. Heart disease and stroke statistics–2015 update: a report from the American Heart Association;Mozaffarian;Circulation,2015

4. The inflammatory response in myocardial injury, repair, and remodelling;Frangogiannis;Nat. Rev. Cardiol.,2014

5. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities;Ong;Pharmacol. Ther.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of injectable hydrogels in the treatment of bone tissue diseases;Chemical Engineering Journal;2024-10

2. Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence;Heliyon;2024-08

3. Targeted delivery of factors and cells for improving cardiac tissue regeneration and heart function following myocardial infarction;Engineered Regeneration;2024-06

4. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-05-31

5. IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction;Inflammopharmacology;2024-04-27